Enter a Search String |
| Special character and space not allowed in the query term. Search string should be at least 2 characters long. |
Molecule Parameter List for degraded | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| The statistics table lists the distribution of a molecule acting either as a substrate, product, enzyme or as a molecule within the network. The text color of a molecule is highlighted by color. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Statistics | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| degraded participated as | Molecule | Sum total of | Enzyme | Substrate of an enzyme | Product of an enzyme | Substrate in Reaction | Product in Reaction |
| No. of occurrences | 9 | 0 | 0 | 0 | 20 | 0 | 13 |
Accession and Pathway Details |
| Accession Name | Accession No. | Accession Type | Pathway Link |
cycle | 85 | Network | Growth, CELLDIV, Rb_grp, IE_GRP, CycB_Grp, Cdc20_Grp, Cdh1_grp, E2F, CycA_Grp, CycE_grp, Early_Response_Genes, Delayed_Response_Genes, CycD_Grp |
| This is a fairly complete mass-action reimplementation of the Novak and Tyson mammalian cell cycle model. It is inexact on two counts. First, it replaces many rather abstracted equations with mass action and Michaelis-Menten forms of enzymes. Second, it does not handle the halving of cellular volume at the division point. Within these limitations, the model does most of what the original paper shows including oscillation of the relevant molecules. | |||
degraded acting as a Molecule in Mammalian_cell_cycle Network
| Name | Accession Name | Pathway Name | Initial Conc. (uM) | Volume (fL) | Buffered | |
| degraded | cycle Accession No. : 85 | CycB_Grp Pathway No. : 1073 | 0 | 200 | No | |
| degraded | cycle Accession No. : 85 | Growth Pathway No. : 1069 | 0 | 200 | Yes | |
| degraded | cycle Accession No. : 85 | IE_GRP Pathway No. : 1072 | 0 | 200 | Yes | |
| degraded | cycle Accession No. : 85 | Cdc20_Grp Pathway No. : 1074 | 0 | 200 | Yes | |
| degraded | cycle Accession No. : 85 | CycA_Grp Pathway No. : 1077 | 0 | 200 | Yes | |
| degraded | cycle Accession No. : 85 | CycE_grp Pathway No. : 1078 | 0 | 200 | Yes | |
| degraded | cycle Accession No. : 85 | Genes Pathway No. : 1079 | 0 | 200 | Yes | |
| Degraded products of Early Response Genes. Just a place- filler pool, does not enter elsewhere. | ||||||
| degraded | cycle Accession No. : 85 | Response_Genes Pathway No. : 1080 | 0 | 200 | Yes | |
| Degraded products of Early Response Genes. Just a place- filler pool, does not enter elsewhere. | ||||||
| degraded | cycle Accession No. : 85 | CycD_Grp Pathway No. : 1081 | 0 | 200 | Yes | |
degraded acting as a Product of an Enzyme in Mammalian_cell_cycle Network
| Enzyme Molecule / Enzyme Activity | Accession Name | Pathway Name | Km (uM) | kcat (s^-1) | Ratio | Enzyme Type | Reagents | |
| 1 | CycE / Ak6_etaE | cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 10.0002 | 500 | 4 | explicit E-S complex | Substrate CycA_Kip1 Product CycA degraded |
| Rate = V6 * [CycD_Kip1]. 6 Apr 2005. Rates were k1 = 500, k2 = 10, k3 = 1 in explicit E.S reaction form. Changed to MM as Km was too low. New values: Km = 10 kcat = Km * k6 * etaE = 500. | ||||||||
| 2 | CycE / k8_CycE | cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 0.1 | 2 | 4 | explicit E-S complex | Substrate CycE Product degraded |
| Autocatalysis step equation 5. Unfortunately cannot exactly represent the math of Equation 26. Note that we cannot merge this enzyme with k6_etaE because this is in the explicit form to get a little closer to the mathematical form. | ||||||||
| 3 | CycE / k6_E_etaE | cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 10.0002 | 500 | 4 | explicit E-S complex | Substrate CycE_Kip1 Product CycE degraded |
| k6 = 100, etaE = 0.5 Assume a large Km of 1000 so that the conc of the enzyme is negligible. Then rate is E.S.Vmax/Km. 6 April 2006 I had changed it over to an explict form earlier. Those values were k1 = 500, k2 = 10, k3 = 1. Cannot use as effective Km is very small so we would end up with lots of E.S complex. Change back to MM: Km = 10, kcat = Km * k6 * etaE = 500. | ||||||||
| 4 | CycE / k6_D_etaE | cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 10.0002 | 500 | 4 | explicit E-S complex | Substrate CycD_Kip1 Product CycD degraded |
| Rate = V6 * [CycD_Kip1]. k3.k1/k2 = rate = k6 * etaE = 50. 6 Apr 2005. Old rates in explicit form were k1 = 500, k2 = 10, k3 = 1. Need to go back to MM form because the above explict rates give a very low Km, ie, lots of E.S complex. k6 = 100, etaE = 0.5, Let Km >> substrate, so Km = 10. Then kcat = Km * k6 * etaE = 500. | ||||||||
| 5 | CycE / k8_CycE_Kip1 | cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 0.1 | 2 | 4 | explicit E-S complex | Substrate CycE_Kip1 Product Kip1 degraded |
| Autocatalysis step equation 5. Unfortunately cannot exactly represent the math of Equation 26. Note that we cannot merge this enzyme with k6_etaE because this is in the explicit form to get a little closer to the mathematical form. | ||||||||
| 6 | CycA / Ak6_etaA | cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 10.0002 | 500 | 4 | explicit E-S complex | Substrate CycA_Kip1 Product CycA degraded |
| See Ak6_etaE | ||||||||
| 7 | CycA / k8_CycA | cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 0.1 | 2 | 4 | explicit E-S complex | Substrate CycE Product degraded |
| 8 | CycA / k6_E_etaA | cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 10.0002 | 500 | 4 | explicit E-S complex | Substrate CycE_Kip1 Product CycE degraded |
| See notes for k6_E_etaE. Explicit rates had been k1 = 500, k2 = 10, k3 = 1 but this gave a very low Km. So, back to MM: etaA = 0.5 so kcat = 500, Km = 10 as for k6_E_etaE | ||||||||
| 9 | CycA / k6_D_etaA | cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 10.0002 | 500 | 4 | explicit E-S complex | Substrate CycD_Kip1 Product CycD degraded |
| k3.k1/k2 = k6.etaA = 100*0.5 = 50 Also k3 << k2. Assume ratio is 10. Let k3 be reasonable, say 1. Then k2 = 10, k1 = 500. 6 April 2005: The above rates are bad because they give a very low Km and too much E.S. complex. So, back to MM: Km >> substrate, so Km = 10. Then kcat = Km * k6 * etaA = 10 * 100 * 0.5 = 500. | ||||||||
| 10 | CycA / k8_CycA_Kip1 | cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 0.1 | 2 | 4 | explicit E-S complex | Substrate CycE_Kip1 Product Kip1 degraded |
| 11 | CycB / Ak6_etaB | cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 9.99992 | 1000 | 4 | explicit E-S complex | Substrate CycA_Kip1 Product CycA degraded |
| See Ak6_etaE | ||||||||
| 12 | CycB / k8_CycB | cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 0.0999992 | 0.1 | 4 | explicit E-S complex | Substrate CycE Product degraded |
| 13 | CycB / k6_E_etaB | cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 9.99992 | 1000 | 4 | explicit E-S complex | Substrate CycE_Kip1 Product CycE degraded |
| See notes for k6_E_etaE. Here etaB = 1 so kcat = 1000, Km as before is 10 | ||||||||
| 14 | CycB / k6_D_etaB | cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 9.99992 | 1000 | 4 | explicit E-S complex | Substrate CycD_Kip1 Product CycD degraded |
| 6 Apr 2005. Earlier used explicit E.S complex form with k1 = 1000, k2 = 10, k3 = 1. This gave low Km and lots of E.S. complex. So shift to MM form: k6 = 100, etaB = 1. Let Km = 10 >> substrate. Then kcat = Km * k6 * etaB = 1000 | ||||||||
| 15 | CycB / k8_CycB_Kip1 | cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 0.0999992 | 0.1 | 4 | explicit E-S complex | Substrate CycE_Kip1 Product Kip1 degraded |
| k8 = 0.2, psiB = 0.05, so kcat = 0.1. J8 = 0.1 | ||||||||
| 16 | Cdc20 / k2_prime_prime | cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 99.9992 | 100 | 4 | explicit E-S complex | Substrate CycB Product degraded |
| k2_prime_prime = 1. rate = k2_prime_prime * Cdc20 * CycB Using MM: rate = kcat * Cdc20 * CycB / (CycB + Km) Let Km >> CycB, ie, around 100. Then kcat = k2_prime_prime * Km = 100. | ||||||||
| 17 | Cdc20 / Cdc20_deg_CycA | cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 10 | 200 | 4 | explicit E-S complex | Substrate CycA Product degraded |
| Rate comes in as k30 = 20 Rate = [Cdc20]*[CycA] * k30. To put in MM form: Rate = [Cdc20]*[CycA] * kcat / (Km + [CycA]) where kcat = k30 * Km and Km >> [CycA]. Put Km = 1000, so kcat = 20000 25 March: use explicit enz form. Use rate = k3*k1/k2 = 20, which works if k2 >> k3. Then let k3 = 1, k2 = 10, k1 becomes 200 7 Apr 2005: Above won't work because of low Km consuming too much of the Cdc20 in the complex form. So use Km = 10, kcat = 200. | ||||||||
| 18 | Cdc20 / Kip1 | cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 10 | 200 | 4 | explicit E-S complex | Substrate CycA_Kip1 Product Kip1 degraded |
| Rate comes in as k30 = 20 Same rate as for CycA alone. Rate = [Cdc20]*[CycA_Kip1] * k30. To put in MM form: Rate = [Cdc20]*[CycA_Kip1] * kcat / (Km + [CycA_Kip1]) where kcat = k30 * Km and Km >> [CycA_Kip1]. Put Km = 1000, so kcat = 20000 Similar to CycA alone, we instead get k2 = 10, k3 = 1, so k1 = 200. 19 Apr 2005: Go back to MM form because of low Km. Let Km = 10, then kcat = Km * k30 = 200. | ||||||||
| 19 | Cdh1_i / Cdh1_i_k2_prime | cycle Accession No. : 85 | Cdh1_grp Pathway No. : 1075 | 100.002 | 5 | 4 | explicit E-S complex | Substrate CycB Product degraded |
| k2_prime = 0.05. so actually this reaction is pretty negligible. rate = k2_prime * Cdh1_i * CycB From MM kinetics, rate = kcat * Cdh1_i * CycB / (CycB + Km). Let Km >>CycB, so Km = 10. Then kcat = k2_prime * Km = 0.5 | ||||||||
| 20 | Cdh1 / Cdh1_k2 | cycle Accession No. : 85 | Cdh1_grp Pathway No. : 1075 | 100 | 2000 | 4 | explicit E-S complex | Substrate CycB Product degraded |
| k2 = 20 Let Km = 100, so it is >> substrate. Then kcat = Km * k2 = 2000 | ||||||||
degraded acting as a Product in a reaction in Mammalian_cell_cycle Network
| Kd is calculated only for second order reactions, like nA+nB <->nC or nA<->nC+nD, where n is number and A,B,C,D are molecules, where as for first order reactions Keq is calculated. Kd for higher order reaction are not consider. |
| Name | Accession Name | Pathway Name | Kf | Kb | Kd | tau | Reagents | |
| 1 | k28 | cycle Accession No. : 85 | Growth Pathway No. : 1069 | 0.2 (s^-1) | 0 (s^-1) | - | - | Substrate GM Product degraded |
| k28 = 0.2 | ||||||||
| 2 | k34 | cycle Accession No. : 85 | IE_GRP Pathway No. : 1072 | 0.05 (s^-1) | 0 (s^-1) | - | - | Substrate PPX Product degraded |
| 3 | k12 | cycle Accession No. : 85 | Cdc20_Grp Pathway No. : 1074 | 1.5 (s^-1) | 0 (s^-1) | - | - | Substrate Cdc20 Product degraded |
| 4 | k12A | cycle Accession No. : 85 | Cdc20_Grp Pathway No. : 1074 | 1.5 (s^-1) | 0 (s^-1) | - | - | Substrate Cdc20notA Product degraded |
| 5 | k_prime6 | cycle Accession No. : 85 | CycA_Grp Pathway No. : 1077 | 10 (s^-1) | 0 (uM^-1 s^-1) | - | - | Substrate CycA_Kip1 Product CycA degraded |
| 6 | k_prime6 | cycle Accession No. : 85 | CycE_grp Pathway No. : 1078 | 10 (s^-1) | 0 (uM^-1 s^-1) | - | - | Substrate CycE_Kip1 Product CycE degraded |
| 7 | k_prime_8 | cycle Accession No. : 85 | CycE_grp Pathway No. : 1078 | 0.1 (s^-1) | 0 (s^-1) | - | - | Substrate CycE Product degraded |
| k_prime_8 = 0.1 | ||||||||
| 8 | k_prime_8_kip1 | cycle Accession No. : 85 | CycE_grp Pathway No. : 1078 | 0.1 (s^-1) | 0 (uM^-1 s^-1) | - | - | Substrate CycE_Kip1 Product Kip1 degraded |
| k_prime_8 = 0.1 | ||||||||
| 9 | k16 | cycle Accession No. : 85 | Genes Pathway No. : 1079 | 0.25 (s^-1) | 0 (s^-1) | - | - | Substrate ERG Product degraded |
| k16 from paper = 0.25, unidirectional degradation step. | ||||||||
| 10 | k18 | cycle Accession No. : 85 | Response_Genes Pathway No. : 1080 | 10 (s^-1) | 0 (s^-1) | - | - | Substrate DRG Product degraded |
| k18 = 10 | ||||||||
| 11 | k10 | cycle Accession No. : 85 | CycD_Grp Pathway No. : 1081 | 5 (s^-1) | 0 (s^-1) | - | - | Substrate CycD Product degraded |
| 12 | k_prime6 | cycle Accession No. : 85 | CycD_Grp Pathway No. : 1081 | 10 (s^-1) | 0 (uM^-1 s^-1) | - | - | Substrate CycD_Kip1 Product CycD degraded |
| 13 | k10_b | cycle Accession No. : 85 | CycD_Grp Pathway No. : 1081 | 5 (s^-1) | 0 (uM^-1 s^-1) | - | - | Substrate CycD_Kip1 Product Kip1 degraded |
| This is another degradation step for CycD, but it happens while the CycD is bound to Kip1. Same rate as k10. | ||||||||
color.